X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES ORCHID PHARMA LTD SUVEN LIFESCIENCES/
ORCHID PHARMA LTD
 
P/E (TTM) x 18.9 -0.2 - View Chart
P/BV x 3.7 0.1 2,695.1% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 SUVEN LIFESCIENCES   ORCHID PHARMA LTD
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-18
ORCHID PHARMA LTD
Sep-13
SUVEN LIFESCIENCES/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs251194 129.3%   
Low Rs15535 442.9%   
Sales per share (Unadj.) Rs49.1276.5 17.8%  
Earnings per share (Unadj.) Rs9.7-79.2 -12.3%  
Cash flow per share (Unadj.) Rs11.4-43.5 -26.2%  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs60.353.9 111.8%  
Shares outstanding (eoy) m127.2870.45 180.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.10.4 997.3%   
Avg P/E ratio x20.9-1.4 -1,444.4%  
P/CF ratio (eoy) x17.8-2.6 -675.9%  
Price / Book Value ratio x3.42.1 158.5%  
Dividend payout %15.40-   
Avg Mkt Cap Rs m25,8258,067 320.2%   
No. of employees `0001.12.8 38.3%   
Total wages/salary Rs m6132,527 24.2%   
Avg. sales/employee Rs Th5,832.66,956.1 83.8%   
Avg. wages/employee Rs Th571.5902.5 63.3%   
Avg. net profit/employee Rs Th1,153.8-1,993.0 -57.9%   
INCOME DATA
Net Sales Rs m6,25319,477 32.1%  
Other income Rs m233407 57.1%   
Total revenues Rs m6,48519,884 32.6%   
Gross profit Rs m1,9821,103 179.7%  
Depreciation Rs m2132,519 8.5%   
Interest Rs m465,227 0.9%   
Profit before tax Rs m1,955-6,236 -31.4%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m718-125 -573.7%   
Profit after tax Rs m1,237-5,580 -22.2%  
Gross profit margin %31.75.7 559.9%  
Effective tax rate %36.72.0 1,829.9%   
Net profit margin %19.8-28.7 -69.0%  
BALANCE SHEET DATA
Current assets Rs m5,62211,014 51.0%   
Current liabilities Rs m1,16832,060 3.6%   
Net working cap to sales %71.2-108.1 -65.9%  
Current ratio x4.80.3 1,401.6%  
Inventory Days Days8195 85.8%  
Debtors Days Days3634 107.1%  
Net fixed assets Rs m3,32529,440 11.3%   
Share capital Rs m127705 18.1%   
"Free" reserves Rs m7,5472,043 369.5%   
Net worth Rs m7,6743,800 202.0%   
Long term debt Rs m149,018 0.2%   
Total assets Rs m9,13546,510 19.6%  
Interest coverage x43.2-0.2 -22,383.4%   
Debt to equity ratio x02.4 0.1%  
Sales to assets ratio x0.70.4 163.4%   
Return on assets %14.0-0.8 -1,848.1%  
Return on equity %16.1-146.9 -11.0%  
Return on capital %26.0-3.7 -697.1%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m5,0667,513 67.4%   
Fx outflow Rs m2,0015,649 35.4%   
Net fx Rs m3,0651,865 164.4%   
CASH FLOW
From Operations Rs m6991,682 41.6%  
From Investments Rs m-6-9,860 0.1%  
From Financial Activity Rs m-5776,644 -8.7%  
Net Cashflow Rs m116-1,535 -7.6%  

Share Holding

Indian Promoters % 63.4 32.3 196.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.6 -  
FIIs % 0.0 3.3 -  
ADR/GDR % 0.0 4.6 -  
Free float % 36.5 55.3 66.0%  
Shareholders   37,287 84,811 44.0%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   PFIZER  GSK PHARMA  PANACEA BIOTECH  DR. REDDYS LAB  ABBOTT INDIA  

Compare SUVEN LIFESCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Yes Bank's Road Ahead(Podcast)

The stock markets witnessed selling pressure in the week gone by. Market participants remained cautious tracking tepid quarterly earnings amid weak cues.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Jul 19, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS